Skip navigation
Monash University, Medicine, Nursing and Health Sciences
  • Staff Intranet
  •   |  
  • Staff Directory
  • Home

  • About Us

  • Study

  • Research

  • Industry

  • Alumni

  • News and Events

  • Giving to the faculty

Monash University > Medicine, Nursing and Health Sciences > School of Biomedical Sciences > Microbiology > Staff >

Dr Anton Peleg

  • SOBS Home
  • Microbiology Home
  • About Us
  • People
  • Research
    • Groups
    • Publications
  • Services and Facilities
    • MICROMON
    • Leptospira Diagnostic Serology
  • For Students
    • Undergraduate
    • Honours
    • Postgraduate
    • Microbiology Postgraduate Society (MUMPS)
  • Employment Opportunities
  • Monash Microbiology
    - 50 Years

 

 

NHMRC R.D. Wright Career Development Fellow
Location: Department of Microbiology, Building 76, level 1, Room 153, Monash University, Clayton
Tel: +61 3 99029159
Fax: +61 3 99029222
E-mail: anton.peleg@monash.edu

Location: Department of Microbiology, Building 76, level 1, Room 153, Monash University, Clayton
Tel: +61 3 99029159
Fax: +61 3 99029222
E-mail: anton.peleg@monash.edu

MBBS (Hons), 1998 Monash University
PhD (Deans Award), Microbiology and Infectious Diseases, 2010, University of Queensland
MPH, 2009, Harvard School of Public Health, Boston, MA USA
FRACP, 2005, Australian College of Physicians

Collaborations:

Dr. Ana Traven (Dept of Molecular Biology and Biochemistry)

  • Candida albicans virulence

Ass/Prof Ben Howden (Austin Centre for Infection Research, Austin Hospital)

  • Pathogenic and resistance mechanisms of Staphylococcus aureus

Assoc/Prof Graham Lieschke (Australian Regenerative Medicine Institute, Monash University)

  • Study of host-pathogen interactions using Zebrafish 

Research Activities:

Our research program focuses on the mechanisms of pathogenesis of important hospital-acquired pathogens. More specifically, Acinetobacter baumannii, an emerging gram-negative bacterium, Staphylococcus aureus, a gram-positive bacterium, and Candida albicans, the most common human fungal pathogen. We combine bacterial and fungal genetic techniques with exciting in vivo infection model systems (mammalian and non-mammalian [Caenorhabditis elegans and Zebrafish) to characterise the role of novel genes in virulence and antimicrobial resistance. Our over-arching goal is to identify new targets that may be amenable for future drug development, with a focus on microbial virulence, persistence and adaptation.

About Us

  • Dean's message
  • Heads of Schools, Departments and Institutes
  • Faculty leadership and senior management
  • Schools and departments
  • Centres and institutes
  • Monash University Medical Foundation
  • Indigenous Health
  • Diversity and inclusion
  • Contact us

Study

  • Current students
  • Future students
  • Study.Monash
  • Alternative pathways

Research

  • How we do research
  • Research capabilities
  • Centres and institutes
  • Postgraduate research
  • Find an expert

Industry

  • Why work with us
  • Ways we can help your business
  • Contact the BDM team
  • Find an expert

Alumni

  • Alumni newsletter
  • Faculty events
  • Monash University Medical Foundation
  • Holding a reunion
  • Meet our alumni
  • Update your details
  • Contact us

News and events

  • Upcoming events
  • Latest news

Staff

  • Intranet
  • My.Monash Portal
  • ESS
  • Professional Development
  • Facilities and Services
  • eSolutions
M8 Alliance logo Group of Eight logo
Copyright © 2020 Monash University ABN 12 377 614 012 – Caution – Privacy – Monash University CRICOS Provider Number: 00008C, Monash College CRICOS Provider Number: 01857J – Last updated: 25 September 2015 – Maintained by webmaster@med.monash.edu.au – Accessibility information